Efficacy of Dihydroartemisinin for Treating PCOS
NCT06417099
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:
Dihydroartemisinin
Sponsor
Shanghai Zhongshan Hospital